Israel Englander’s AnaptysBio ANAB Stock Holding History

Israel Englander’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	+15,000	New	+$909K	﹤0.01%	4304
2025 Q4	–	Sell	-10,100	Closed	-$309K	–	5981
2025 Q3	$309K	Buy	+10,100	New	+$232K	﹤0.01%	5325
2021 Q2	–	Sell	-22,800	Closed	-$491K	–	6483
2021 Q1	$491K	Buy	+22,800	New	+$575K	﹤0.01%	4844
2020 Q1	–	Sell	-72,900	Closed	-$1.19M	–	3802
2019 Q4	$1.19M	Sell	72,900 -390,000	-84%	-$9.22M	﹤0.01%	2928
2019 Q3	$16.2M	Buy	+462,900	New	+$22M	0.03%	933
2018 Q3	–	Sell	-50,800	Closed	-$3.61M	–	3863
2018 Q2	$3.61M	Buy	+50,800	New	+$4.26M	﹤0.01%	2020

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's ANAB Position: Q2 2026 in Review

Israel Englander increased its AnaptysBio (ANAB) stake by 70% in Q2 2026, buying an estimated $20.1M and bringing the position to 807,316 shares worth $54.5M. The position accounts for 0.02% of the portfolio, ranked #845.

Israel Englander first reported a position in ANAB in Q1 2017 and has held it in 36 quarters since. 211 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Israel Englander held 807,316 shares of AnaptysBio worth $54.5M as of Q2 2026.
Israel Englander bought 331,744 AnaptysBio shares in Q2 2026, an estimated $20.1M.
AnaptysBio made up 0.02% of Israel Englander's portfolio in Q2 2026, its #845 holding.
Israel Englander first reported a position in AnaptysBio in Q1 2017 and has held it in 36 quarters since.
211 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.